MedPath

Impact of Lower Body Weight Support Treadmill on Cardiopulmonary Exercise Capacity and Trainability

Not Applicable
Completed
Conditions
Healthy Volunteers
Interventions
Other: AlterG Anti-gravity treadmill
Registration Number
NCT02951494
Lead Sponsor
University Medicine Greifswald
Brief Summary

The AlterG®-anti-gravity treadmill provides lower body weight support which enables individuals to exercise without feeling their full body weight. How this body weight support influences cardiovascular, respiratory, vascular and metabolic parameters is currently unclear. Further, whether body weight support influences the trainability in response to moderate continuous exercise is unknown. This investigation has two main goals. First, we explore the direct influence of lower body weight support on cardiometabolic parameters during maximal exercise testing. Second, we aim to compare changes in cardiorespiratory fitness in response to a structured exercise protocol using moderate intensity with and without lower body weight support.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • maximal oxygen consumption below age-sex specific standard
Exclusion Criteria
  • acute infection within the last four weeks
  • anemia (males: Hb < 8.1 mmol/L; females Hb < 7.4 mmol/L)
  • previous reports of myo-, endo, or pericarditis
  • previous stroke or acute myocardial infarction
  • heart failure (NYHA > 1)
  • aortic valve stenosis
  • congenital heart disease
  • cardiomyopathy
  • severe left ventricular hypertrophy
  • cardiac arrythmias
  • hypertension
  • diabetes
  • BMI > 35
  • cancer
  • pregnancy
  • aneurysm of aorta or cerebral arteries

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AlterG Anti-gravity treadmillAlterG Anti-gravity treadmillcont. aerobic exercise training with lower body weight support
Primary Outcome Measures
NameTimeMethod
Maximal oxygen consumption12 weeks

VO2peak \[ml/min\]

Secondary Outcome Measures
NameTimeMethod
Pulse wave velocity12 weeks
Oxygen consumption at anaerobic threshold12 weeks

VO2@AT

Trial Locations

Locations (1)

Cardiovascular examination center of the University Medicine Greifswald

🇩🇪

Greifswald, Germany

© Copyright 2025. All Rights Reserved by MedPath